Lupin Gets 1 Observation for Tarapur Facility After USFDA cGMP Inspection sheeba farhat12 Feb 2026 11:17 PM ISTMumbai: Pharma major Lupin has announced the completion of a cGMP inspection carried out by the United States Food and Drug Administration (USFDA) at...
Lupin's Indore Plant Gets 6 Observations After USFDA Inspection sheeba farhat11 Feb 2026 8:26 PM ISTMumbai: Pharma major Lupin has announced the completion of a United States Food and Drug Administration (USFDA) inspection at its Pithampur Unit-2...
Lupin Settles Mirabegron Patent Dispute With Astellas for USD 90 Million, Clears US Sales sheeba farhat10 Feb 2026 8:00 PM ISTUnder the agreement, Lupin and its U.S. unit will pay Astellas a USD 75 million upfront payment and per-unit licensing fees on Mirabegron sales...
Lupin signs licensing pact with Gan & Lee Pharma for GLP-1 receptor agonist Bofanglutide Ruchika Sharma30 Dec 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has entered into an exclusive License, Supply and Distribution agreement with Gan...
Eli Lilly, Novo Nordisk race to lock in India obesity drug market Ruchika Sharma26 Dec 2025 4:23 PM ISTHyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming obesity drug market,...
Lupin, Neopharmed sign licensing pact for Gastro brand Plasil in Brazil, Philippines Ruchika Sharma18 Dec 2025 5:23 PM ISTPlasil is widely acknowledged for its efficacy in treating nausea, vomiting, and motility disorders.
Lupin receives positive EMA comittee opinion for eye therapy Ranluspec Ruchika Sharma17 Dec 2025 12:58 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
Lupin Nagpur injectable facility gets EIR from USFDA Ruchika Sharma17 Dec 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States...
Lupin secures SBTi validation for emission reduction targets Ruchika Sharma16 Dec 2025 10:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that its greenhouse gas (GHG) emissions reduction targets have been officially validated by...
Counterfeit Drug Racket Using Lupin Brand Busted in Puducherry, FIR Filed Parthika Patel14 Dec 2025 2:00 PM ISTPuducherry: The misuse of the Lupin pharmaceutical brand in the manufacture and circulation of fake medicines has come under renewed scrutiny after...
Lupin Manufacturing Solutions, PolyPeptide Group forge long term Peptide alliance Ruchika Sharma12 Dec 2025 2:41 PM ISTMumbai: Lupin Manufacturing Solutions, a subsidiary of global pharma major Lupin has announced a long-term strategic alliance with PolyPeptide...
Lupin secures tentative USFDA nod for multiple sclerosis drug Siponimod Ruchika Sharma5 Dec 2025 11:10 AM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received tentative approval from the United States Food and Drug...
